首页|关节镜下踝关节距腓前韧带缝线、PLUS缝线及胫腓前韧带最远束移植增强修复术的疗效

关节镜下踝关节距腓前韧带缝线、PLUS缝线及胫腓前韧带最远束移植增强修复术的疗效

扫码查看
目的:探讨关节镜下踝关节距腓前韧带(ATFL)缝线增强修复、PLUS缝线增强修复和胫腓前韧带远束(ATiFL-DF)移植增强修复的近期临床疗效.方法:纳入 2019 年 6 月至 2021 年 2 月接受手术治疗的 67 例ATFL损伤患者,随访24 个月.其中,25 例患者接受ATFL缝线增强修复(缝线增强组),22 例患者接受PLUS缝线增强修复(PLUS缝线增强组),20 例患者接受 ATiFL-DF 移植增强修复(生物增强组).使用美国骨科足踝协会(AOFAS)评分、足踝能力测量(FAAM)评分、视觉模拟量表(VAS)评分和应力放射图来评估结果.结果:术后 1和3 个月,生物增强组患者的AOFAS评分明显低于缝线增强组和PLUS缝线增强组(1 个月AOFAS评分,生物增强组为78.2±7.2,缝线增强组为83.7±5.7,PLUS缝线增强组为85.0±6.2,P=0.002;3 个月AOFAS评分,生物增强组为86.9±4.3,缝线增强组为91.2±3.6,PLUS缝线增强组为 91.8±3.7,P<0.001).术后 1 和 3 个月,生物增强组的VAS评分显著高于缝线增强组和PLUS缝线增强组(1 个月VAS评分,生物增强组为 3.5±1.2,缝线增强组为2.6±1.1,PLUS缝线增强组为2.8±0.8,P=0.001;3 个月VAS评分,生物增强组为2.9±1.1,缝线增强组为2.1±1.3,PLUS缝线增强组为2.0±1.0,P=0.001).此外,术后 6 月、12 个月和 24 个月,3 个治疗组在AOFAS、VAS、FAAM和应力放射图方面的差异无统计学意义(P>0.05).结论:ATFL缝线增强修复、PLUS缝线增强修复和ATiFL-DF移植增强修复能够获得有效的治疗效果.与缝线增强修复和PLUS缝线增强修复相比,ATiFL-DF移植增强修复的早期疼痛更为显著.
Clinical outcomes of arthroscopic all-inside anterior talofibular ligament suture augmentation repair,PLUS suture augmentation repair and anterior tibiofibular ligament distal fascicle transfer augmentation repair
Objective:To explore the short-term clinical efficacy of anterior talofibular ligament(ATFL)suture augmentation repair,PLUS suture augmentation repair and anterior tibiofibular ligament's distal fascicle(ATiFL-DF)transfer augmentation repair under arthroscopy.Methods:The retrospective study included a cohort of sixty-seven patients who underwent surgical treatment for an anterior talofibular ligament(ATFL)injury between June 2019 and February 2021,with a follow-up period of two years.The patient groupings consisted of 25 individuals who underwent ATFL suture augmentation repair(suture group),22 who received the PLUS suture augmentation repair(PLUS suture group),and 20 who were treated with ATiFL-DF transfer augmentation repair(biological group).Postoperative evaluations were conducted using a suite of standardized measures,including the American orthopaedic foot and ankle society(AOFAS)score,foot and ankle ability measure(FAAM)score,visual analogue scale(VAS)score,and stress radiographs.Results:At 1 and 3 months postoperatively,the AOFAS score of patients in the biological group was significantly lower than that in the suture group and PLUS suture group(AOFAS score of 1 month is 78.2±7.2,83.7±5.7 and 85.0±6.2 in biological group,suture group and PLUS suture group respectively,P=0.002;AOFAS score of 3 months is 86.9±4.3,91.2±3.6 and 91.8±3.7 in biological group,suture group and PLUS suture group respectively,P<0.001).At 1 and 3 months postoperatively,the VAS scores in the biological group were significantly higher than those in the suture group and PLUS suture group(VAS score of 1 month is 3.5±1.2,2.6±1.1 and 2.8±0.8 in biological group,suture group and PLUS suture group respectively,P=0.001;VAS score of 3 months is 2.9±1.1,2.1±1.3 and 2.0±1.0 in biological group,suture group and PLUS suture group respectively,P=0.001).In addition,6 months,12 months,and 24 months postoperatively,there were no significant differences among the three treatment groups in terms of AOFAS,VAS,FAAM,and stress radiogram(P>0.05).Conclusion:ATFL suture augmentation repair,PLUS suture augmentation repair,and ATiFL-DF transfer augmentation repair have all demonstrated efficacious therapeutic outcomes.However,it was observed that the early postoperative pain experienced by patients who underwent the ATiFL-DF transfer augmentation repair was more intense when compared to those who received suture augmentation repair and PLUS suture augmentation repair.

ankle arthroscopyanterior talofibular ligamentsuture augmentation repairPLUS suture augmentation repairATiFL-DF transfer augmentation repairclinical efficacy

李锐军、陈心茹、胡大海、李涛、肖磊、侯辉歌

展开 >

中山市港口医院 骨科,广东 中山 528400

暨南大学 第一临床医学院 运动医学科∥广州市精准骨科与再生医学重点实验室∥广东省速度能力研究重点实验室,广东 广州 510630

暨南大学 生物医学转化研究院,广东 广州 510630

踝关节镜 距腓前韧带 缝线增强修复 PLUS缝线增强修复 ATiFL-DF移植增强修复 临床疗效

广州市科技计划-市校联合资助项目

202201020087

2024

暨南大学学报(自然科学与医学版)
暨南大学

暨南大学学报(自然科学与医学版)

CSTPCD北大核心
影响因子:0.996
ISSN:1000-9965
年,卷(期):2024.45(3)
  • 1